<DOC>
	<DOCNO>NCT02768259</DOCNO>
	<brief_summary>- Measuring incidence prevalence PAH Egyptian patient different type MCD - Determination survival &amp; risk factor mortality .</brief_summary>
	<brief_title>Prevalence Pulmonary Arterial Hypertension Patients With Connective Tissue Diseases Egyptian Patients</brief_title>
	<detailed_description>PH define mean pulmonary artery pressure great 25 mmHg . PAH assess different mean , however right heart catheterization ( RHC ) gold standard diagnostic method . Among different subgroup pulmonary arterial hypertension ( PAH ) , associate connective tissue disease ( CTDs ) specific entity distinct hemodynamic prognostic feature reflect importance rheumatological assessment PAH , especially unfavorable prognostic impact patient . Compared patient idiopathic PAH , patient CTD-associated PAH high mortality lower walk distance 6-minute walk test , high level B-type natriuretic peptide , bad right ventricular function , left-sided heart dysfunction , low lung function , pericardial disease . That 's , PAH screen routinely perform systemic sclerosis ( SSc ) CTDs also , suggest international guideline , important rule CTDs patient PAH , patient diagnose idiopathic PAH ( iPAH ) may associate CTD previously unrecognized . Although similarity pathogenesis PAH CTD systemic sclerosis ( SSc ) , systemic lupus erythematosus ( SLE ) , mixed connective tissue disease ( MCTD ) , variability outcomes patient CTD-associated PAH .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Connective Tissue Diseases</mesh_term>
	<criteria>Patients diagnose connective tissue disease fulfil ACR criterion recruit non</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>